Skeletal muscle apolipoprotein B expression reduces muscular triglyceride accumulation

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 74, Issue 4, 2014, Pages 351-357

  Bartels, Emil D ^a,b   Ploug, Thorkil ^c   Storling, Joachim ^b,d   Mandrup Poulsen, Thomas ^c,d,e   Nielsen, Lars B ^a,c  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d STENO DIABETES CENTER   (Denmark)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Apolipoprotein B; Insulin resistance; NIDDM; Obesity; Skeletal muscle

Indexed keywords

APOLIPOPROTEIN B; GLUCOSE; INSULIN; MESSENGER RNA; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HEART MUSCLE; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID LIVER LEVEL; LIPID STORAGE; LIPOPROTEIN SECRETION; MALE; MOUSE; NONHUMAN; OBESITY; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; SOLEUS MUSCLE; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIPID METABOLISM; LIVER; METABOLISM; MOUSE MUTANT; PANCREAS; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION (PROCESS); TRANSGENIC MOUSE;

ANIMALS; APOLIPOPROTEINS B; BLOOD GLUCOSE; GENE EXPRESSION REGULATION; HUMANS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MALE; MICE, OBESE; MICE, TRANSGENIC; MUSCLE, SKELETAL; OBESITY; PANCREAS; TRIGLYCERIDES;

EID: 84902253469     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2014.893446     Document Type: Article

References (33)

1. Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003; 144: 5159-65.
2. Due P, Heitmann BL, Sorensen TI. Prevalence of obesity in Denmark. Obes Rev 2007; 8: 187-9.
3. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-55.
4. Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008; 28: 27-38.
5. Heni M, Machann J, Staiger H, Schwenzer NF, Peter A, Schick F, Claussen CD, Stefan N, Haring HU, Fritsche A. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev 2010; 26: 200-5.
6. Poitout V, Robertson RP. Minireview: secondary beta-cell failure in type 2 diabetes-a convergence of glucotoxicity and lipotoxicity. Endocrinology 2002; 143: 339-42.
7. Harmon JS, Gleason CE, Tanaka Y, Poitout V, Robertson RP. Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats. Diabetes 2001; 50: 2481-6.
8. Kelley DE, Goodpaster BH. Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes Care 2001; 24: 933-41.
9. Unger RH, Orci L. Lipotoxic diseases of nonadipose tissues in obesity. Int J Obes Relat Metab Disord 2000; 24(Suppl. 4): S28-32.
10. Pimenta AS, Gaidhu MP, Habib S, So M, Fediuc S, Mirpourian M, Musheev M, Curi R, Ceddia RB. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells. J Cell Physiol 2008; 217: 478-85.
11. Bell JA, Reed MA, Consitt LA, Martin OJ, Haynie KR, Hulver MW, Muoio DM, Dohm GL. Lipid partitioning, incomplete fatty acid oxidation, and insulin signal transduction in primary human muscle cells: effects of severe obesity, fatty acid incubation, and fatty acid translocase/ CD36 overexpression. J Clin Endocrinol Metab 2010; 95: 3400-10.
12. Holland WL, Brozinick JT, Wang LP, Hawkins ED, Sargent KM, Liu Y, Narra K, Hoehn KL, Knotts TA, Siesky A, Nelson DH, Karathanasis SK, Fontenot GK, Birnbaum MJ, Summers SA. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat- and obesity-induced insulin resistance. Cell Metab 2007; 5: 167-79.
13. Madsen EM, Lindegaard ML, Andersen CB, Damm P, Nielsen LB. Human placenta secretes apolipoprotein B-100- containing lipoproteins. J Biol Chem 2004; 279: 55271-6.
14. Gautier T, Becker S, Drouineaud V, Menetrier F, Sagot P, Nofer JR, von OS, Lagrost L, Masson D, Tietge UJ. Human luteinized granulosa cells secrete apoB100-containing lipoproteins. J Lipid Res 2010; 51: 2245-52.
15. Krzystanek M, Pedersen TX, Bartels ED, Kjaehr J, Straarup EM, Nielsen LB. Expression of apolipoprotein Bin the kidney attenuates renal lipid accumulation. J Biol Chem 2010; 285: 10583-90.
16. Fujihara M, Bartels E, Nielsen LB, Handa JT. Ahuman apoB100 transgenic mouse expresses human apoB100 in the RPE and develops features of early AMD. Exp Eye Res 2009; 88: 1115-23.
17. Bartels ED, Nielsen JM, Hellgren LI, Ploug T, Nielsen LB. Cardiac expression of microsomal triglyceride transfer protein is increased in obesity and serves to attenuate cardiac triglyceride accumulation. PLoS One 2009; 4: e5300.
18. Nielsen LB, Bartels ED, Bollano E. Overexpression of apolipoprotein Bin the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice. J Biol Chem 2002; 277: 27014-20.
19. Nielsen LB, Sullivan M, Vanni-Reyes T, Goldberg IJ, Young SG. The DNA sequences required for apolipoprotein Bexpression in the heart are distinct from those required for expression in the intestine. J Mol Cell Cardiol 1999; 31: 695-703.
20. Linton MF, Farese RV Jr, Chiesa G, Grass DS, Chin P, Hammer RE, Hobbs HH, Young SG. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J Clin Invest 1993; 92: 3029-37.
21. Bartels ED, Bang CA, Nielsen LB. Early atherosclerosis and vascular inflammation in mice with diet-induced type 2 diabetes. Eur J Clin Invest 2009; 39: 190-9.
22. Brunstedt J, Nielsen J, Lernmark Å. The Hagedorn Study Group: isolation of islets from mice and rats. Meth Diabetes Res (Lab meth C) 1984; 254-88.
23. Nielsen K, Karlsen AE, Deckert M, Madsen OD, Serup P, Mandrup-Poulsen T, Nerup J. Beta-cell maturation leads to in vitro sensitivity to cytotoxins. Diabetes 1999; 48: 2324-32.
24. Ihlemann J, Galbo H, Ploug T. Calphostin Cis an inhibitor of contraction, but not insulin-stimulated glucose transport, in skeletal muscle. Acta Physiol Scand 1999; 167: 69-75.
25. Pedersen TX, Bro S, Andersen MH, Etzerodt M, Jauhiainen M, Moestrup S, Nielsen LB. Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein- Edeficient mice. Atherosclerosis 2009; 202: 372-81.
26. Bro S, Bentzon JF, Falk E, Andersen CB, Olgaard K, Nielsen LB. Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice. J Am Soc Nephrol 2003; 14: 2466-74.
27. Nielsen LB, Perko M, Arendrup H, Andersen CB. Microsomal triglyceride transfer protein gene expression and triglyceride accumulation in hypoxic human hearts. Arterioscler Thromb Vasc Biol 2002; 22: 1489-94.
28. Bartels ED, Lauritsen M, Nielsen LB. Hepatic expression of microsomal triglyceride transfer protein and in vivo secretion of triglyceride-rich lipoproteins are increased in obese diabetic mice. Diabetes 2002; 51: 1233-9.
29. Bjorkegren J, Veniant M, Kim SK, Withycombe SK, Wood PA, Hellerstein MK, Neese RA, Young SG. Lipoprotein secretion and triglyceride stores in the heart. J Biol Chem 2001; 276: 38511-7.
30. Kutlu B, Burdick D, Baxter D, Rasschaert J, Flamez D, Eizirik DL, Welsh N, Goodman N, Hood L. Detailed transcriptome atlas of the pancreatic beta cell. BMC Med Genomics 2009; 2: 3.
31. Kumashiro N, Erion DM, Zhang D, Kahn M, Beddow SA, Chu X, Still CD, Gerhard GS, Han X, Dziura J, Petersen KF, Samuel VT, Shulman GI. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci USA 2011; 108: 16381-5.
32. Raabe M, Flynn LM, Zlot CH, Wong JS, Veniant MM, Hamilton RL, Young SG. Knockout of the abetalipoproteinemia gene in mice: reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes. Proc Natl Acad Sci USA 1998; 95: 8686-91.
33. Roduit R, Masiello P, Wang SP, Li H, Mitchell GA, Prentki M. Arole for hormone-sensitive lipase in glucose-stimulated insulin secretion: a study in hormone-sensitive lipase-deficient mice. Diabetes 2001; 50: 1970-5.